CHAMP T 2 Pilot of CIMT by Tele-Video

Description

The CHAMP-T2 study is a pilot test of the efficacy of constraint induced movement therapy (CIMT) when delivered by tele-video in the child's home or home-like environment. This study will examine the pre-, post-intervention function a hemiparetic limb in children who have hemiplegic cerebral palsy. The purpose is to provide an effect size estimate that will inform the design of a future study that will compare tele-delivered CIMT with usual and customary care.

Conditions

Hemiplegic Cerebral Palsy

Talk to us

Study Overview

On this page

Study Details

Study overview

The CHAMP-T2 study is a pilot test of the efficacy of constraint induced movement therapy (CIMT) when delivered by tele-video in the child's home or home-like environment. This study will examine the pre-, post-intervention function a hemiparetic limb in children who have hemiplegic cerebral palsy. The purpose is to provide an effect size estimate that will inform the design of a future study that will compare tele-delivered CIMT with usual and customary care.

Efficacy of Constraint Induced Movement Therapy Delivered by Tele-Video for Children With Hemiplegic Cerebral Palsy

CHAMP T 2 Pilot of CIMT by Tele-Video

Condition
Hemiplegic Cerebral Palsy
Intervention / Treatment

-

Contacts and Locations

Columbus

The Ohio State University School of Health and Rehabilitation Sciences, Columbus, Ohio, United States, 43210

Roanoke

Virginia Tech-Fralin Biomedical Research Institute, Roanoke, Virginia, United States, 24016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Children who have hemiplegic cerebral palsy, ages 5-10; who have hemiparesis ranging from Manual Ability Classification System (MACS) II to MACS IV, and live within a 1.5 hour distance from therapists' worksites at the Ohio State University Wexner Medical Center in Columbus, Ohio, or the Fralin Biomedical Research Institute in Roanoke, Virginia
  • * Previous high dose CIMT (defined as CIMT given 2 hrs per day for 10 days); Treatment with botulinum toxin for spasticity in the 3 months preceding baseline assessment; Surgery for spasticity in the 6 months preceding baseline assessment; Medically unstable and unable to participate in the treatment intervention; Child is behaviorally or cognitively impaired so unable to participate in the treatment intervention; Family unable to participate in tele-delivery of CIMT 5 days a week for 4 weeks; the caregiver available at child's treatment site during treatment times is unable to communicate with the treating therapist.

Ages Eligible for Study

5 Years to 10 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Warren Lo,

Warren Lo, MD, PRINCIPAL_INVESTIGATOR, Nationwide Children's Hospital

Study Record Dates

2027-06-30